Women's Health Innovation Series: Contraception Summit | Kisaco Research

Women's Health Innovation Series: Contraception Summit

Driving innovation, education, and investment to improve access to and quality of women’s contraception journeys

Download 2021 Agenda
VIRTUAL SUMMIT | PDT Timezone
23 February, 2021

“When I lie awake thinking of women and their health globally, I remind myself: the world has made a lot of progress in recent years…Too many women are still missing out on the opportunity to get educated, support themselves, and obtain the health services they need, when they need them”

Dr Flavia Bustreo, Assistant Director General for Family, Women’s and Children’s Health through the Life-course, World Health Organization

WHY ATTEND?

Women’s health today is under-served from innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players (incl. investors and insurers). It is imperative to develop the eco-system, shift mindsets and embrace the holistic women-centred approach.

As part of our leading Women’s Health Innovation Series, The Contraception Innovation Summit is the first instalment of our 1-day themed events throughout 2021. Take a deep-dive into the verticals that are driving change in women’s health to improve the quality and access to healthcare for women globally. 

Innovation in the contraception industry is long overdue. Women's desire to take ownership over their birth control, demanding more choice, safety, efficacy and education has become a vehicle for innovation and investment in this space.

The Contraception Summit is about putting women at the centre of contraceptive research, innovations, and education to improve women’s contraceptive journeys throughout their lives. Join our leading network of pharma, biotech, medical device companies, start-ups, investors, researchers, and HCPs to drive innovation at the convergence of healthcare and technology.

WHIS Steering Committee 2021

Author:

Maryjane Lacoste

Senior Program Officer for Family Planning Service Delivery and Quality
Bill and Melinda Gates Foundation

Maryjane Lacoste joined The Bill and Melinda Gates Foundation in May 2014, working with the Family Planning Team as the Senior Program Officer for Family Planning Service Delivery and Quality.  As such, she led the implementation of the Implant Access Program and currently leads and manages the DMPA-SC introduction/scale portfolio, ensuring that the strategy focuses on expanding access to method choice and strengthens quality of care including counseling, interpersonal communications, clinical training, service delivery and performance monitoring.  She also oversees the family planning portfolio in Indonesia and guides on postpartum and postabortion FP strategies.  Prior to joining the Foundation, Maryjane worked with Jhpiego for over 20 years, spending the last 15 years in the field as country/regional director in Tanzania, Indonesia and Malawi.  She has worked with Ministries of Health, donors and other stakeholders to develop and manage implementation of large reproductive health, maternal, newborn and child health and HIV projects in many countries in sub-Saharan Africa, as well as in Indonesia. Maryjane holds a Master of Arts degree from University of Maryland and a Bachelor of Arts degree from Loyola University.

Author:

Alice Zheng, MD, MBA, MPH

Women’s Health Practice Leader
McKinsey & Company

Author:

Susan C. Nicholson, MD, FIDSA

Vice President, Women’s Health
Johnson & Johnson

Author:

Dr. Stephen Gerrard Ph.D.

Independent Expert Advisor Contraception R&D

Author:

Jarrad Aguirre

Head of Corporate Strategy and Advocacy
Myovant Sciences

Jarrad Aguirre, MD, MBA, is Head of Corporate Strategy and Advocacy at Myovant Sciences, a healthcare company focused on women's health and prostate cancer. In this role, he oversees corporate communications, patient advocacy, and digital strategy, and serves on the Executive Committee. 
 
Prior to joining Myovant, Jarrad worked as a physician, researcher, and consultant across the spectrum of health and healthcare, including at Brigham and Women's Hospital (a teaching hospital of Harvard Medical School), The Colorado Health Foundation, the Bill & Melinda Gates Foundation, and Collective Health. 
 
He graduated with honors from Yale University and University of Oxford, where he studied as a Rhodes Scholar. He completed the MD/MBA at Stanford University, supported by the Jack Kent Cooke Foundation Graduate Scholarship.  

Contraception Innovation Spotlight

From research to finished product, highlighting the key innovations in the contraception space, from hormonal to non-hormonal solutions, devices, digital health innovations and therapeutics. 8 finalists, selected by our prestigious selection committee, showcase their innovations to our audience and get priority access to our meeting platform.

SUBMISSION DEADLINE:  FEBRUARY 5TH, 2021

APPLY NOW

1
Day
30+
Industry Leading Speakers
4+
Dedicated Networking Hours
5+
In-depth Case Studies
200+
Industry Executives

WOMEN'S HEALTH INNOVATION SERIES 2021 CALENDAR

dates.png

2021 Contraception Innovation Speakers

 

Maryjane Lacoste

Senior Program Officer for Family Planning Service Delivery and Quality
Bill and Melinda Gates Foundation

Maryjane Lacoste joined The Bill and Melinda Gates Foundation in May 2014, working with the Family Planning Team as the Senior Program Officer for Family Planning Service Delivery and Quality.  As such, she led the implementation of the Implant Access Program and currently leads and manages the DMPA-SC introduction/scale portfolio, ensuring that the strategy focuses on expanding access to method choice and strengthens quality of care including counseling, interpersonal communications, clinical training, service delivery and performance monitoring.  She also oversees the family planning port

Maryjane Lacoste

Senior Program Officer for Family Planning Service Delivery and Quality
Bill and Melinda Gates Foundation

Maryjane Lacoste

Senior Program Officer for Family Planning Service Delivery and Quality
Bill and Melinda Gates Foundation

Maryjane Lacoste joined The Bill and Melinda Gates Foundation in May 2014, working with the Family Planning Team as the Senior Program Officer for Family Planning Service Delivery and Quality.  As such, she led the implementation of the Implant Access Program and currently leads and manages the DMPA-SC introduction/scale portfolio, ensuring that the strategy focuses on expanding access to method choice and strengthens quality of care including counseling, interpersonal communications, clinical training, service delivery and performance monitoring.  She also oversees the family planning portfolio in Indonesia and guides on postpartum and postabortion FP strategies.  Prior to joining the Foundation, Maryjane worked with Jhpiego for over 20 years, spending the last 15 years in the field as country/regional director in Tanzania, Indonesia and Malawi.  She has worked with Ministries of Health, donors and other stakeholders to develop and manage implementation of large reproductive health, maternal, newborn and child health and HIV projects in many countries in sub-Saharan Africa, as well as in Indonesia. Maryjane holds a Master of Arts degree from University of Maryland and a Bachelor of Arts degree from Loyola University.

 

Amy Welsh

Vice President Marketing
Agile Therapeutics

Amy Welsh

Vice President Marketing
Agile Therapeutics

Amy Welsh

Vice President Marketing
Agile Therapeutics
 

Malyse Uwase

Director of Health & Impact
Kasha

Malyse Uwase

Director of Health & Impact
Kasha

Malyse Uwase

Director of Health & Impact
Kasha
 

Sabrina Johnson

President & CEO
Daré Bioscience

Sabrina Johnson

President & CEO
Daré Bioscience

Sabrina Johnson

President & CEO
Daré Bioscience
 

Stasia Obremskey

Partner
Rhia Ventures

Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar.

Stasia Obremskey

Partner
Rhia Ventures

Stasia Obremskey

Partner
Rhia Ventures

Before joining, Stasia served in 2018 as the first Fellow of the Tara Health Foundation. She has more than twenty-five years of experience providing financial and strategic planning consulting to organizations in the U.S. and Asia. She has joined management teams as the interim Chief Financial Officer on a short term and extended term basis to provide finance, accounting and strategic planning expertise to startups, fast growing companies and non-profit organizations. Current and past clients include 18Birdies, Posit Science, Circlepoint, West Shore Technologies and We Care Solar. She has lived for over 8 years in Bangkok, Thailand and Hong Kong, China. She began her consulting career as a management consultant with Bain & Company. Previously, she worked in investment banking for Morgan Stanley & Co. She holds a bachelor’s degree in Business Administration with a concentration in finance from the University of Notre Dame and an MBA from the Harvard Graduate School of Business. In addition to her consulting work, she has extensive experience as a member of several nonprofit boards where she has held a number of leadership positions.

 

Eva Lathrop, MD, MPH

Global Medical Director
Public Services International

Eva Lathrop, MD, MPH

Global Medical Director
Public Services International

Eva Lathrop, MD, MPH

Global Medical Director
Public Services International
 

Vrunda B Desai, MD

Medical Director
Cooper Surgical

Vrunda B Desai, MD

Medical Director
Cooper Surgical

Vrunda B Desai, MD

Medical Director
Cooper Surgical
 

Kevin Eisenfrats

Co-Founder & CEO
Contraline

Kevin Eisenfrats

Co-Founder & CEO
Contraline

Kevin Eisenfrats

Co-Founder & CEO
Contraline
 

Heather Vahdat

Executive Director
Male Contraceptive Initiative

Heather Vahdat

Executive Director
Male Contraceptive Initiative

Heather Vahdat

Executive Director
Male Contraceptive Initiative
 

Akash Bakshi

CEO
Your Choice Therapeutics

Akash Bakshi

CEO
Your Choice Therapeutics

Akash Bakshi

CEO
Your Choice Therapeutics
 

Dr. Raoul Scherwitzl

Co-Founder & CEO
Natural Cycles

Dr. Raoul Scherwitzl

Co-Founder & CEO
Natural Cycles

Dr. Raoul Scherwitzl

Co-Founder & CEO
Natural Cycles
 

Daniela Schardinger

VP Marketing & Medical Affairs
OCON Healthcare

Daniela Schardinger

VP Marketing & Medical Affairs
OCON Healthcare

Daniela Schardinger

VP Marketing & Medical Affairs
OCON Healthcare
 

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions

Rachel Scherl

Co-Founder & Managing Partner
Spark Solutions
 

Clint Dart

Vice President, Biostatistics and Programming
Health Decisions

Clint Dart

Vice President, Biostatistics and Programming
Health Decisions

Clint Dart

Vice President, Biostatistics and Programming
Health Decisions
 

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures

Maria Velissaris

Founding Partner
Steel Sky Ventures
 

Sofia Noori MD, MPH

Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department

Dr. Sofia Noori is a third-year resident physician in the Yale Department of Psychiatry. At Yale she serves as the curriculum lead for Innovation to Impact, a NIDA-funded substance use entrepreneurship program that helps addiction researchers and clinicians commercialize their insights for the public good.  She is a founding member of the Center for Digital Psychiatry at the Connecticut Mental Health Center, which aims to integrate digital health in the care of patients with serious mental illness. Dr.

Sofia Noori MD, MPH

Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department

Sofia Noori MD, MPH

Yale Psychiatry Resident, Digital Mental Health
Yale Psychiatry Department

Dr. Sofia Noori is a third-year resident physician in the Yale Department of Psychiatry. At Yale she serves as the curriculum lead for Innovation to Impact, a NIDA-funded substance use entrepreneurship program that helps addiction researchers and clinicians commercialize their insights for the public good.  She is a founding member of the Center for Digital Psychiatry at the Connecticut Mental Health Center, which aims to integrate digital health in the care of patients with serious mental illness. Dr. Noori is a 2019 scholar at Flare Capital Partners in Boston, MA.

 

Aside from her endeavors in digital health, Dr. Noori deeply cares about the wellbeing of women. She is the co-founder of the Women’s Mental Health Conference at Yale, the first trainee-led women’s mental health conference in the world.  Dr. Noori also co-founded the Yale Women’s Housestaff Organization, which advocates for improved working conditions for the over 700 women residents and fellows at Yale.

 

Dr. Noori is an MD graduate of the PRIME program at UCSF School of Medicine, a dual-degree program that trains emerging physician-leaders to transform care for underserved populations. She received her MPH in health policy and management at UC Berkeley. She is passionate about women’s mental health and the use of technology to improve health equity.  

 

 

Barbara Dehn

Women’s Health Practitioner
El Camino Women’s Medical Group

Barb Dehn is a practicing Women’s Health Nurse Practitioner in Silicon Valley and a television health expert, who’s known as Nurse Barb on NBC’s California Live. An award winning author, active in Social Media and YouTube, Barb earned a masters degree from UCSF and a BS from Boston College. She is certified by the North American Menopause Society and is a Fellow in the American Association of Nurse Practitioners.  She works on Global Health Initiatives at FAME Hospital in Karatu, Tanzania, where she serves on their board and as a volunteer.

 

Barbara Dehn

Women’s Health Practitioner
El Camino Women’s Medical Group

Barbara Dehn

Women’s Health Practitioner
El Camino Women’s Medical Group

Barb Dehn is a practicing Women’s Health Nurse Practitioner in Silicon Valley and a television health expert, who’s known as Nurse Barb on NBC’s California Live. An award winning author, active in Social Media and YouTube, Barb earned a masters degree from UCSF and a BS from Boston College. She is certified by the North American Menopause Society and is a Fellow in the American Association of Nurse Practitioners.  She works on Global Health Initiatives at FAME Hospital in Karatu, Tanzania, where she serves on their board and as a volunteer.

 

 

Bethany Young Holt, PhD MPH

Executive Director & Founder
CAMI Health

Bethany Young Holt, PhD MPH

Executive Director & Founder
CAMI Health

Bethany Young Holt, PhD MPH

Executive Director & Founder
CAMI Health
 

David Feigal

Partner
Ex FDA, NDA Partners

David Feigal

Partner
Ex FDA, NDA Partners

David Feigal

Partner
Ex FDA, NDA Partners
 

Sheryl A. Kingsberg

Chief, Devision of Behavioral Medicine, Department of OB/GYN
University Hospitals Cleveland Medical Center

Sheryl A. Kingsberg

Chief, Devision of Behavioral Medicine, Department of OB/GYN
University Hospitals Cleveland Medical Center

Sheryl A. Kingsberg

Chief, Devision of Behavioral Medicine, Department of OB/GYN
University Hospitals Cleveland Medical Center
 

Daniel Davis

Founder
Ex FDA, Davis Reproductive Health Consulting, LLC

Daniel Davis

Founder
Ex FDA, Davis Reproductive Health Consulting, LLC

Daniel Davis

Founder
Ex FDA, Davis Reproductive Health Consulting, LLC
 

Annie Theriault

Managing Partner
Grand Challenges

Annie Theriault, Ph.D., CFA, ICD.D

 

Annie Theriault

Managing Partner
Grand Challenges

Annie Theriault

Managing Partner
Grand Challenges

Annie Theriault, Ph.D., CFA, ICD.D

 

Annie is the Chief Investment Officer of Grand Challenges Canada and the Managing Director of the EWEC Innovation Marketplace, an initiative of the Bill & Melinda Gates Foundation, Grand Challenges Canada, NORAD, and USAID. Annie is also the Managing Partner of Cross-Border Impact Ventures, a new impact investment firm partnered with Grand Challenges Canada to launch a health technology venture capital fund focused on women’s, children’s and adolescents’ health investing with a gender lens. She is a Founding Member of The Big Push, an accelerator for women-led tech companies, and an advisor to Silver Maple Ventures, a Toronto-Based fintech company offering a full suite of solutions for private placements in early and growth stage companies. Prior to these roles, Annie spent most of her career investing in private companies as a venture capitalist and lender across multiple sectors and stages, including several impact investments.

 

Annie obtained her PhD in Management from the Rotman School of Management at the University of Toronto, is a CFA Charterholder and holds the ICD.D designation.

 

 

 

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital

Anula Jayasuriya

Founder and Managing Director
EXXclaim Capital
 

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group

Marta Hill Gray

Executive Director
Gray Matter Group
 

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo is a member of the private equity team at HBM Partners, a Swiss-based healthcare investment firm with approximately $1.8 billion in assets under management. He has been responsible for investments in more than 15 private biotech, medical device and diagnostics companies in the United States and Europe, in most cases as a board member or board observer. Collectively, these companies have so far generated five NASDAQ IPOs, five M&A transactions and four FDA-approved marketed products.

 

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo

Partner
HBM Partners

Chandra P. Leo is a member of the private equity team at HBM Partners, a Swiss-based healthcare investment firm with approximately $1.8 billion in assets under management. He has been responsible for investments in more than 15 private biotech, medical device and diagnostics companies in the United States and Europe, in most cases as a board member or board observer. Collectively, these companies have so far generated five NASDAQ IPOs, five M&A transactions and four FDA-approved marketed products.

 

In the women’s health field, Chandra has backed and worked with companies focused on e.g. cervical cancer, endometriosis, uterine fibroids, gynecologic infections, urogynecologic conditions, infertility and preterm labor. Before becoming a venture capital investor, he served as a physician in the Dept. of OB/GYN at the University Hospital in Leipzig, Germany, and completed a postdoctoral fellowship in reproductive biology at Stanford University.

 

Chandra holds degrees as a Doctor of Medicine from the Freie Universität Berlin (Charité), a Master in Medicines Development (MAS) from the University of Basel, and an MBA with distinction from INSEAD (France/Singapore). He lives in Zurich with his wife (a gynecologist) and their two daughters.  

 

 

Lisa Rarick, MD

Clinical/Regulatory Consultant
Ex FDA, RAR Consulting, LLC

Lisa Rarick, MD

Clinical/Regulatory Consultant
Ex FDA, RAR Consulting, LLC

Lisa Rarick, MD

Clinical/Regulatory Consultant
Ex FDA, RAR Consulting, LLC
 

Jenny Yip

Managing Partner
Adjuvant Capital

Jenny Yip

Managing Partner
Adjuvant Capital

Jenny Yip

Managing Partner
Adjuvant Capital
 

Nelson Ambrogio

Senior Vice President and General Manager Women’s Healthcare
Bayer Pharmaceuticals US

Nelson is a highly-respected and dynamic business leader who is dedicated to delivering innovative health care solutions to enhance people’s lives.

Nelson Ambrogio

Senior Vice President and General Manager Women’s Healthcare
Bayer Pharmaceuticals US

Nelson Ambrogio

Senior Vice President and General Manager Women’s Healthcare
Bayer Pharmaceuticals US

Nelson is a highly-respected and dynamic business leader who is dedicated to delivering innovative health care solutions to enhance people’s lives.


As the leader of the Bayer Women’s Healthcare team, he is responsible for Bayer’s leading contraceptive portfolio, with revenues in excess of 900m$ and leading a cross-functional organization of more than 300 team members.
In his previous role, Nelson led the Bayer Pharmaceuticals team in Australia and New Zealand, where he was responsible for the launch of blockbuster drugs including Xarelto (cardiovascular) and Eylea (ophthalmology) and guiding a team of more than 250 people.


Nelson’s career spans more than 20 years with Bayer and Schering in both mature and emerging markets across Latin America, Europe and Australasia. He has held the position of managing director of Bayer Portugal, business unit director General Medicine, Bayer Brazil and assistant to a Bayer Board Member at the company’s headquarters in Germany.
Nelson started his career at Schering in his native Uruguay and was instrumental in the program management of the Bayer-Schering integration in Latin America and Canada.

 

Diana Blithe, Ph.D.

Chief, Contraceptive Development Program, DIPHR, NICHD
NIH

Diana Blithe, Ph.D.

Chief, Contraceptive Development Program, DIPHR, NICHD
NIH

Diana Blithe, Ph.D.

Chief, Contraceptive Development Program, DIPHR, NICHD
NIH

DOWNLOAD AGENDA

Please complete the form to access the 2021 WHIS: Contraception Innovation Summit Agenda. 

Take a look at 2019 highlights:

Fill your details below

TICKET PACKAGES

Sending Your Team? Group Discounts Available!

Applicable for Primary Market, Service Provider and Industry Rates Only. Not available for Academic or ‘Start-Up’ rates

Book a Team of 3+ - Save an Additional 10% Off
Book a Team of 5+ - Save an Additional 15% Off

If you would like to register a team of 3 or more, please email [email protected] for your discount coupon code before registering. PLEASE NOTE: Discounts cannot be combined with Early Bird Pricing or any other discount or offer. If you have any questions about your registration, please call us on +44 (0)20 3696 2920

We accept the following cards through Stripe:
Saturday, December 19, 2020 to Friday, January 29, 2021
Emerging
$199
FemTech & Digital Health Companies, incl. Venture Capital, Angel Investors (less than $10 million)
Save $100 on your conference ticket - Book before Jan 29
1 day conference ticket
Access to networking platform
Access to content 2 months post event
Saturday, December 19, 2020 to Friday, January 29, 2021
Industry
$499
Pharma, Biotech, Medical Devices, Diagnostics, Multinational & Corporate (more than $10 million)
Save $200 on your conference ticket - Book before Jan 29
1 day conference ticket
Access to networking platform
Access to content 2 months post event
Saturday, December 19, 2020 to Friday, January 29, 2021
Service Provider
$599
Consultants & Industry Vendors, Investment Banks, Private Equity
Save $200 on your conference ticket - Book before Jan 29
1 day conference ticket
Access to networking platform
Access to content 2 months post event
Preparing registration...

Partners

Event Partner

Media Partners

The Virtual Experience

Top 10 benefits

- Tailor Your Agenda 

- More Audience Participation

- Improved Audience Visibility 

- On-Demand Content

- High Quality Speakers 

- More Networking Opportunities 

- Save Time & Money 

- Increased Content 

- More insights 

- Business Development Opportunities - Talk to our team to find out out more [email protected].

Platform Preview

BECOME A MEDIA PARTNER

If you're interested in becoming a media partner, please contact Katie Horne: [email protected]

Become a Sponsor

Kisaco Research provides the much-needed platform on which industry executives can network, connect and learn from each other as well as meet potential industry partners.

Far from the typical ‘meet-and-greet’ exhibition experience, you – as a sponsor or exhibitor – will be positioned as a partner of the event with a focus on the benefits of your product and brand, rather than just a name on an exhibition list.

With our extensive marketing experience and strategy, your partnership with Kisaco Research will grant you a sponsorship package that is an extension and enhancement of your current marketing and branding efforts. We value your ROI and will work with you directly on your specific goals and targets – that’s why we take special care in finding the most relevant end-users to attend, so that your financial and resource investment is smartly allocated.

Find out more by calling us at +44 (0)20 3696 2920 or email us at [email protected].

About Kisaco Research

Kisaco Research produces, designs and hosts B2B industry conferences, exhibitions and communities – focused on a specialized selection of topic areas.

Meet industry peers that will help build a career-changing network for life.

Learn from the mistakes of your peers as much as their successes—ambitious industry stalwarts who are happy to share not just what has made them successful so far but also their plans for future proofing their companies.

Note down the inspired insight that will form the foundation for future strategies and roadmaps, both at our events and through our online communities.

Invest both in your company growth and your own personal development by signing up to one of our events and get started.

Other events you might be interested in:

Women's Health Innovation Summit 2021